During the last session, Tevogen Bio Holdings Inc (NASDAQ:TVGN)’s traded shares were 0.72 million, with the beta value of the company hitting -0.80. The 52-week high for the TVGN share is $3.09, that puts it down -183.49 from that peak though still a striking 76.15% gain since the share price plummeted to a 52-week low of $0.26. The company’s market capitalization is $200.44M, and the average trade volume was 924.06K shares over the past three months.
Tevogen Bio Holdings Inc (NASDAQ:TVGN) trade information
The stock’s 5-day price performance is 7.92%, and it has moved by -2.68% in 30 days. Based on these gigs, the overall price performance for the year is 10.05%.
While earnings are projected to return 43.59% in 2025, the next five years will return 6.73% per annum.
TVGN Dividends
Tevogen Bio Holdings Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.91 million shares, is of PORTLAND GLOBAL ADVISORS LLC’s that is approximately 1.2393% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.38 million.
Also, the Mutual Funds coming in first place with the largest holdings of Tevogen Bio Holdings Inc (TVGN) shares are Fidelity Salem Street Trust-Fidelity Small Cap Index Fund and iShares Trust-iShares Russell 2000 Growth ETF . Data provided on Feb 28, 2025 indicates that Fidelity Salem Street Trust-Fidelity Small Cap Index Fund owns about 230.06 shares. This amounts to just over 0.13 percent of the company’s overall shares, with a $0.25 million market value. The same data shows that the other fund manager holds slightly less at 144.87, or about 0.08% of the stock, which is worth about $0.16 million.